Mission & Vision
Our goal is to provide innovative technologies that optimizes platin treatments, helping doctors focus on patients most likely to benefit, reducing toxicity and overtreatment
Our mission is to revolutionize cancer care through research-driven, personalized therapies that are both safer and more effective. Traditional chemotherapies like cisplatin, though critical in treating various cancers, can suffer from high toxicity, limited response rates, and resistance, impacting patient quality of life and outcomes. At CHOSA, we are the only company with a tool that can predict which patients will benefit from cisplatin treatment and which will not. By delivering the right treatment to the right patient, CHOSA is setting a new standard for precision medicine and working toward higher response rates.
A different approach through Intelligent Oncology
Our strategy is driven by our core values
Patient-centered innovation: We prioritize advancements that enhance response rates and minimize toxicity, improving both patient experience and outcomes.
Commitment to personalization: We believe in a future where treatment is as unique as each patient, focusing on tailored solutions that are both safe and effective.
Compassion and protection: Our commitment to safeguarding patients from ineffective treatments underlines our dedication to their well-being.
Excellence in combination therapy: By combining cisplatin and PD-(L)1 inhibitors, we are setting new standards for cancer treatment through innovative approaches.